A prospective, multicenter, large sample registry-based study of Angong Niuhuang Pills for Stroke
Phase 4
- Conditions
- Stroke
- Registration Number
- ITMCTR2100005305
- Lead Sponsor
- Integrated Hospital of Traditional Chinese Medicine, Southern Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. The subject was clinically diagnosed with acute stage of stroke and the responsible lesion (infarct or hemorrhage foci) appeared on imaging, and the subject was prescribed Angong Niuhuang Pills for more than 3 days.
2. The Chinese medicine diagnosis is phlegm-heat internal closure evidence
3. Subjects voluntarily enrolled in this study and signed a written informed consent form.
Exclusion Criteria
1. Patients with stroke caused by brain tumor, traumatic brain injury, hematological disease, rheumatic heart disease, coronary heart disease and other heart disease combined with atrial fibrillation.
2. Other patients who are considered by the investigator to be inappropriate for participation in this study.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IHSS;Modified Rankin Scale;
- Secondary Outcome Measures
Name Time Method